Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Beginning Cash Balance: 2020-2025

Historic Beginning Cash Balance for InMed Pharmaceuticals (INM) over the last 6 years, with Jun 2025 value amounting to $6.6 million.

  • InMed Pharmaceuticals' Beginning Cash Balance rose 69.59% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year decrease of 16.12%. This contributed to the annual value of $6.6 million for FY2025, which is 26.27% down from last year.
  • As of FY2025, InMed Pharmaceuticals' Beginning Cash Balance stood at $6.6 million, which was down 26.27% from $8.9 million recorded in FY2024.
  • In the past 5 years, InMed Pharmaceuticals' Beginning Cash Balance ranged from a high of $8.9 million in FY2024 and a low of -$1.6 million during FY2021.
  • Its 3-year average for Beginning Cash Balance is $7.2 million, with a median of $6.6 million in 2025.
  • In the last 5 years, InMed Pharmaceuticals' Beginning Cash Balance plummeted by 138.63% in 2021 and then spiked by 572.81% in 2022.
  • InMed Pharmaceuticals' Beginning Cash Balance (Yearly) stood at -$1.6 million in 2021, then soared by 572.81% to $7.4 million in 2022, then fell by 16.11% to $6.2 million in 2023, then surged by 44.29% to $8.9 million in 2024, then decreased by 26.27% to $6.6 million in 2025.